Biological agent for treating myopia as well as preparation method and use method thereof

A biological agent, a technique for myopia

Pending Publication Date: 2020-10-23
重庆康视美科技有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The above reports only initially revealed the basic role of basic fibroblast growth factor and transforming growth factor-β on the growth of human scleral fibroblasts, how to apply basic fibroblast growth factor and transforming growth fac

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biological agent for treating myopia as well as preparation method and use method thereof
  • Biological agent for treating myopia as well as preparation method and use method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-3

[0040] The only difference between Examples 1-3 is that the contents of basic fibroblast growth factor, transforming growth factor and mouse nerve growth factor are different. The content of basic fibroblast growth factor, transforming growth factor and mouse nerve growth factor in the embodiment 1-3 is specifically referred to the following table:

[0041] test group basic fibroblast growth factor transforming growth factor mouse nerve growth factor Example 1 50ug 10ug 5ug Example 2 65ug 20ug 10ug Example 3 80ug 30ug 15ug

[0042] Validity Experiment 1

[0043] Choose 1056 people of myopia patients aged 7-65, divide them into eight groups according to their age groups, use the present invention every day before getting up in the morning (7:00-9:00) and falling asleep at night (21:00-22:00) Biological preparations provided, after 6 months of treatment, count the effective rate and emmetropy rate of the biological preparation...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Growth factoraaaaaaaaaa
Login to view more

Abstract

The invention belongs to the technical field of myopia regulatory diseases, and particularly discloses a biological agent for treating myopia. The biological agent comprises a basic fibroblast growthfactor, 10-30 [mu]g of a transforming growth factor and 5-15 [mu]g of a mouse nerve growth factor, wherein the mass sum of the transforming growth factor and the mouse nerve growth factor is less thanor equal to the mass of the basic fibroblast growth factor, and the mass of the basic fibroblast growth factor is less than or equal to two times the mass sum of the transforming growth factor and the mouse nerve growth factor. The invention also discloses a preparation method and use method of the biological agent for treating the myopia. The biological agent not only can promote self-healing ofthe myopia, but also is high in safety.

Description

technical field [0001] The invention belongs to the technical field of myopia-related accommodative diseases, and in particular relates to a biological preparation for treating myopia, a preparation method and a use method thereof. Background technique [0002] Myopia refers to the state where the eye does not apply the adjustment function. Parallel light rays pass through the refractive system of the eye to form a focus in front of the retina, and then form a scattered and blurred aperture on the retina. This refractive state is called myopia. Myopia can be divided into mild myopia (<300 degrees), moderate myopia (300-600 degrees) and high myopia (>600 degrees). Myopia has rapidly become a global health problem over the past three decades, becoming one of the leading causes of visual impairment and associated with potentially blinding ocular complications including retinal detachment, myopic maculopathy, glaucoma, and cataracts. [0003] Myopia is caused by multiple ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/18A61K9/00A61P27/10
CPCA61K38/1825A61K38/1841A61K38/185A61K9/0048A61P27/10A61K2300/00
Inventor 肖庆兵李金本陈帝江
Owner 重庆康视美科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap